BAI — BenevolentAI SA Share Price
0.000.00%
Last trade - 00:00- €80.48m
- €1.34m
- £7.33m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.74 | ||
| Price to Tang. Book | 0.98 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 9.45 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -78.52% | ||
| Return on Equity | -51.01% | ||
| Operating Margin | -1058.15% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | n/a | n/a | 4.63 | 10.56 | 7.33 | 45.78 | 41.75 | 25.9% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BenevolentAI SA is an artificial intelligence (AI)-enabled drug discovery and development company. Through the combined capabilities of this AI platform, its scientific expertise, and wet-lab facilities, it delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers its in-house drug pipeline and supports collaborations with AstraZeneca, as well as research and charitable institutions. Its pipeline includes BEN-2293, BEN-8744, BEN-9160 and BEN-28010. It integrates data from across domains and data types, including omics, molecules, experiments, literature, pathology and biological systems to provide a holistic view of biology. BEN-8744 is under development as an ulcerative colitis treatment for a novel target discovered using its AI platform. BEN-2293 is a topical PanTrk inhibitor in development to relieve inflammation and rapidly resolve itch in patients with atopic dermatitis.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 4th, 2021
- Public Since
- July 2nd, 2021
- No. of Employees
- 248
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Euronext - Amsterdam
- Shares in Issue
- 121,939,884
- Address
- 4-8 Maple Street, LONDON, W1T 5HD
- Web
- https://www.benevolent.com/
- Phone
- Auditors
- PricewaterhouseCoopers Societe Cooperative
Upcoming Events for BAI
BenevolentAI SA Annual Shareholders Meeting
Similar to BAI
Galapagos NV
Euronext - Amsterdam
Themis Bioscience BV
Euronext - Amsterdam
Vivoryon Therapeutics NV
Euronext - Amsterdam
FAQ
What is the BenevolentAI SA share price?
As of Today at 19:03 UTC, shares in BenevolentAI SA are trading at €0.66. This share price information is delayed by 15 minutes.
How has the BenevolentAI SA share price performed this year?
Shares in BenevolentAI SA last closed at €0.66 and the price had moved by -66.83% over the past 365 days. In terms of relative price strength the BenevolentAI SA share price has underperformed the FTSE Global All Cap Index by -68.86% over the past year.
What are the analyst and broker recommendations for BenevolentAI SA?
The overall consensus recommendation for BenevolentAI SA is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the BenevolentAI SA dividend yield?
BenevolentAI SA does not currently pay a dividend.
Does BenevolentAI SA pay a dividend?
BenevolentAI SA does not currently pay a dividend.
When does BenevolentAI SA next pay dividends?
BenevolentAI SA does not currently pay a dividend.
How do I buy BenevolentAI SA shares?
To buy shares in BenevolentAI SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of BenevolentAI SA?
As of the previous close price of €0.66, shares in BenevolentAI SA had a market capitalisation of €80.48m.
Where are BenevolentAI SA shares listed?
Here are the trading details for BenevolentAI SA:
- Country of listing: Netherlands
- Exchange: AEX
- Ticker Symbol: BAI
What kind of share is BenevolentAI SA?
Based on an overall assessment of its quality, value and momentum BenevolentAI SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a BenevolentAI SA share price forecast for 2024?
The analyst consensus target price for shares in BenevolentAI SA is €2.50. That is 279.4% above the last closing price of €0.66.
Analysts covering BenevolentAI SA currently have a consensus Earnings Per Share (EPS) forecast of -£0.04 for the next financial year.
What is the trend in the BenevolentAI SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BenevolentAI SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -27.79%.
As of the last closing price of €0.66, shares in BenevolentAI SA were trading -28.34% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the BenevolentAI SA PE Ratio?
The BenevolentAI SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.66.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of BenevolentAI SA?
We do not have data on BenevolentAI SA's directors